being retrieved, which is a common problem. Notably, there were no major post-biopsy complications, thereby supporting the safety of core needle biopsy. Although core needle biopsy is a well-established diagnostic procedure for bone tumours, its role to assess musculoskeletal tumours is not well defined, particularly as most soft-tissue tumours can be easily diagnosed by a fine needle aspiration. In the Seng et al. study, 4 the diagnosis of most soft-tissue tumours could also be established by a core needle biopsy, although 5 specimens were reported to be benign but turned out to have a malignant histopathology. This highlights over-dependence on core needle biopsy for some lesions. It is important to note that the diagnosis of haematological malignancies (2 in this series) should depend on bone marrow aspiration, rather than core needle biopsy. The study yielded a sensitivity and specificity of 95% (97/102) and 97% (31/32) for core needle biopsy, respectively, which were comparable to those reported in the literature.
